Stockreport

AC Immune: Maintaining 'Buy' Rating On Next Steps For ACI-7104.056 Development In PD [Seeking Alpha]

AC Immune SA  (ACIU) 
Last ac immune sa earnings: 11/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acimmune.com/en/investors
PDF AC Immune is advancing ACI-7104.056, with upcoming FDA discussions to potentially establish a registration study as a key value-driving catalyst. The company benefits [Read more]